Sym006

Sym006 (undisclosed bacterial target) is a recombinant polyclonal antibody being developed against an undisclosed bacterial pathogen. The program is fully funded by Meiji Holdings Co., Ltd.

 

 

Status
The project is in preclinical development.

 

 

Infectious Disease
Current Partners